Potential gains in PrEP coverage and effect on racial disparities following introduction of on-demand and long-acting injectable PrEP: Preferences of men who have sex with men in the United States, 2021-2022.

IF 2.9 3区 医学 Q3 IMMUNOLOGY JAIDS Journal of Acquired Immune Deficiency Syndromes Pub Date : 2025-01-09 DOI:10.1097/QAI.0000000000003602
Jeb Jones, Aaron J Siegler, Jennifer L Glick, Iaah Lucas, Patrick S Sullivan, Supriya Sarkar, Leigh Ragone, M Keith Rawlings, Vani Vannappagari, Travis Sanchez
{"title":"Potential gains in PrEP coverage and effect on racial disparities following introduction of on-demand and long-acting injectable PrEP: Preferences of men who have sex with men in the United States, 2021-2022.","authors":"Jeb Jones, Aaron J Siegler, Jennifer L Glick, Iaah Lucas, Patrick S Sullivan, Supriya Sarkar, Leigh Ragone, M Keith Rawlings, Vani Vannappagari, Travis Sanchez","doi":"10.1097/QAI.0000000000003602","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>There are persistent race- and ethnicity-based disparities in HIV incidence among gay and bisexual men who have sex with men (GBMSM) in the United States, partially driven by inequities in distribution of pre-exposure prophylaxis (PrEP). We assessed how additional modalities of PrEP beyond daily oral might affect uptake of PrEP and ongoing disparities in HIV incidence in the US.</p><p><strong>Methods: </strong>In an online survey of GBMSM in the US, we presented participants with descriptions of each PrEP modality. Among GBMSM not willing to use daily oral PrEP, we assessed willingness to use on-demand or long-acting injectable (LA) PrEP. Among GBMSM using daily oral PrEP, we assessed willingness to switch to on-demand or LA PrEP.</p><p><strong>Results: </strong>Among GBMSM who were not willing to use daily oral PrEP, most were also not willing to use either on-demand or LA PrEP. In adjusted analyses, Hispanic/Latino, non-Hispanic/Latino Black, and non-Hispanic/Latino GBMSM of other races were more willing to use LA PrEP than non-Hispanic/Latino White GBMSM; none of the adjusted prevalence ratios was statistically significant. Most GBMSM currently taking daily oral PrEP reported a preference for staying on that regimen. Among those interested in switching, most were interested in on-demand PrEP.</p><p><strong>Conclusions: </strong>Most GBMSM not willing to use daily oral PrEP are also not willing to use other modalities of PrEP; most GBMSM who are currently using daily oral PrEP prefer to continue using that dosing strategy. Our results suggest that differential preferences in modalities of PrEP will not exacerbate existing disparities in PrEP distribution or HIV incidence.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003602","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: There are persistent race- and ethnicity-based disparities in HIV incidence among gay and bisexual men who have sex with men (GBMSM) in the United States, partially driven by inequities in distribution of pre-exposure prophylaxis (PrEP). We assessed how additional modalities of PrEP beyond daily oral might affect uptake of PrEP and ongoing disparities in HIV incidence in the US.

Methods: In an online survey of GBMSM in the US, we presented participants with descriptions of each PrEP modality. Among GBMSM not willing to use daily oral PrEP, we assessed willingness to use on-demand or long-acting injectable (LA) PrEP. Among GBMSM using daily oral PrEP, we assessed willingness to switch to on-demand or LA PrEP.

Results: Among GBMSM who were not willing to use daily oral PrEP, most were also not willing to use either on-demand or LA PrEP. In adjusted analyses, Hispanic/Latino, non-Hispanic/Latino Black, and non-Hispanic/Latino GBMSM of other races were more willing to use LA PrEP than non-Hispanic/Latino White GBMSM; none of the adjusted prevalence ratios was statistically significant. Most GBMSM currently taking daily oral PrEP reported a preference for staying on that regimen. Among those interested in switching, most were interested in on-demand PrEP.

Conclusions: Most GBMSM not willing to use daily oral PrEP are also not willing to use other modalities of PrEP; most GBMSM who are currently using daily oral PrEP prefer to continue using that dosing strategy. Our results suggest that differential preferences in modalities of PrEP will not exacerbate existing disparities in PrEP distribution or HIV incidence.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
引入按需和长效注射PrEP后,PrEP覆盖率的潜在收益和对种族差异的影响:2021-2022年美国男男性行为者的偏好
导言:在美国,同性恋和双性恋男男性行为者(GBMSM)的艾滋病毒发病率持续存在种族和民族差异,部分原因是暴露前预防(PrEP)分布不公平。我们评估了每日口服PrEP以外的其他方式如何影响PrEP的吸收和美国HIV发病率的持续差异。方法:在美国的GBMSM在线调查中,我们向参与者介绍了每种PrEP方式的描述。在不愿意使用每日口服PrEP的GBMSM中,我们评估了使用按需或长效注射(LA) PrEP的意愿。在使用每日口服PrEP的GBMSM中,我们评估了转向按需或LA PrEP的意愿。在不愿意每日口服PrEP的GBMSM中,大多数也不愿意使用按需或LA PrEP。在调整分析中,西班牙裔/拉丁裔、非西班牙裔/拉丁裔黑人和其他种族的非西班牙裔/拉丁裔GBMSM比非西班牙裔/拉丁裔白人GBMSM更愿意使用LA PrEP;校正后的患病率均无统计学意义。大多数目前每天服用口服PrEP的GBMSM报告倾向于继续使用该方案。在有意转换的人群中,大多数对按需PrEP感兴趣。结论:大多数GBMSM不愿意使用每日口服PrEP,也不愿意使用其他方式的PrEP;目前使用每日口服PrEP的大多数GBMSM倾向于继续使用该剂量策略。我们的研究结果表明,对PrEP方式的不同偏好不会加剧PrEP分布或HIV发病率的现有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
期刊最新文献
A Review of Network Models for HIV Spread. Estimated Impact of HIV Testing on Length of Stay at Visits to U.S. Emergency Departments, 2018-2021. Brief Report: Pancreatic Cancer in People With HIV: A Case-Control Study. Longitudinal Changes in Tenofovir and Tenofovir Diphosphate Concentrations Among Pregnant Women Using Oral PrEP for HIV Prevention: Findings From Durban, South Africa. Model-Based Prioritization of Adolescent Girls and Young Women for HIV Prevention Services Based on Data From 13 Sub-Saharan African Countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1